the potential of moderately hypofractionated radiotherapy: analysis & future directions
Published 1 year ago • 70 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:15
impact of clinical implementation of hypofractionated radiotherapy on patient quality of life
-
3:10
carbon footprint of the one week ultra hypofractionated breast radiotherapy workflow
-
1:42
fast forward phase iii: hypofractionated whole breast irradiation
-
2:11
optimizing ultra-hypofractionated breast rt: streamlined workflow reduces sessions & transportation
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
2:28
hypofractionated radiotherapy for the management of prostate cancer
-
11:26
the future of radiotherapy for prostate cancer
-
2:48
potential role of radiotherapy for liver cancer
-
3:00
phase ii randomized trial of conventional vs hypofractionated post-mastectomy proton radiotherapy
-
1:10
skagen & hypog-01 trials: hypofractionated rt in early breast cancer reduces arm lymphedema risk
-
1:44
results of the phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
1:26
bridget f. koontz, md, on moderate hypofractionation & ultra-hypofractionation in prostate cancer
-
0:50
dr. jagsi discusses the benefits of hypofractionated radiotherapy for breast cancer
-
2:08
evolution of fractionation regimens in breast cancer radiotherapy: skagen trial 1 and hypog-01 trial
-
1:55
a new regimen of hypofractionated postoperative radiation therapy for breast cancer
-
1:29
the role of radiotherapy in mesothelioma and thymic carcinoma
-
1:01
reducing the risk of cardiac radiation exposure in breast cancer
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer